Molekularpathologie der Lunge

作者: C. Vollbrecht , K. König , L. Heukamp , R. Büttner , M. Odenthal

DOI: 10.1007/S00292-012-1704-7

关键词:

摘要: Lung cancer is one of the most frequent malignancies in western world. Its association with a wide spectrum mutations genes encoding various signal transducers that are often linked to therapy response, emphasizes obvious need for improved, fast and highly efficient approaches molecular pathology. Comprehensive analyses mutation status progression relevant can be performed by novel sequencing forms named next generation (NGS) providing extremely high capacities ultra-deep sequence analyses. The 454 pyrosequencing method, synthesis semiconductor platform now available parallel multitudinous target multiple tumor DNA applications. "one molecule, clone, read" principle NGS supplies not only information on allele frequencies rates but also has advantage very sensitive detection low frequency variants.

参考文章(36)
Sreenath V. Sharma, Daphne W. Bell, Jeffrey Settleman, Daniel A. Haber, Epidermal growth factor receptor mutations in lung cancer Nature Reviews Cancer. ,vol. 7, pp. 169- 181 ,(2007) , 10.1038/NRC2088
Adi F. Gazdar, Personalized Medicine and Inhibition ofEGFRSignaling in Lung Cancer New England Journal of Medicine. ,vol. 361, pp. 1018- 1020 ,(2009) , 10.1056/NEJME0905763
Nancy E. Hynes, Heidi A. Lane, ERBB receptors and cancer: the complexity of targeted inhibitors. Nature Reviews Cancer. ,vol. 5, pp. 341- 354 ,(2005) , 10.1038/NRC1609
Christopher R. Zito, Lucia B. Jilaveanu, Valsamo Anagnostou, David Rimm, Gerold Bepler, Sauveur-Michel Maira, Wolfgang Hackl, Robert Camp, Harriet M. Kluger, Herta H. Chao, Multi-Level Targeting of the Phosphatidylinositol-3-Kinase Pathway in Non-Small Cell Lung Cancer Cells PLoS ONE. ,vol. 7, pp. e31331- ,(2012) , 10.1371/JOURNAL.PONE.0031331
Jonathan M. Rothberg, Wolfgang Hinz, Todd M. Rearick, Jonathan Schultz, William Mileski, Mel Davey, John H. Leamon, Kim Johnson, Mark J. Milgrew, Matthew Edwards, Jeremy Hoon, Jan F. Simons, David Marran, Jason W. Myers, John F. Davidson, Annika Branting, John R. Nobile, Bernard P. Puc, David Light, Travis A. Clark, Martin Huber, Jeffrey T. Branciforte, Isaac B. Stoner, Simon E. Cawley, Michael Lyons, Yutao Fu, Nils Homer, Marina Sedova, Xin Miao, Brian Reed, Jeffrey Sabina, Erika Feierstein, Michelle Schorn, Mohammad Alanjary, Eileen Dimalanta, Devin Dressman, Rachel Kasinskas, Tanya Sokolsky, Jacqueline A. Fidanza, Eugeni Namsaraev, Kevin J. McKernan, Alan Williams, G. Thomas Roth, James Bustillo, An integrated semiconductor device enabling non-optical genome sequencing Nature. ,vol. 475, pp. 348- 352 ,(2011) , 10.1038/NATURE10242
Simon Ekman, Murry W. Wynes, Fred R. Hirsch, The mTOR pathway in lung cancer and implications for therapy and biomarker analysis. Journal of Thoracic Oncology. ,vol. 7, pp. 947- 953 ,(2012) , 10.1097/JTO.0B013E31825581BD
Peter M. Ellis, Normand Blais, Dennis Soulieres, Diana N. Ionescu, Meenakshi Kashyap, Geoff Liu, Barb Melosky, Tony Reiman, Phillippe Romeo, Frances A. Shepherd, Ming-Sound Tsao, Natasha B. Leighl, A Systematic Review and Canadian Consensus Recommendations on the Use of Biomarkers in the Treatment of Non-small Cell Lung Cancer Journal of Thoracic Oncology. ,vol. 6, pp. 1379- 1391 ,(2011) , 10.1097/JTO.0B013E318220CB8E
BO ZOU, SHOUJUAN SUN, XIAOJUAN QI, PING JI, Aldehyde dehydrogenase activity is a cancer stem cell marker of tongue squamous cell carcinoma. Molecular Medicine Reports. ,vol. 5, pp. 1116- 1120 ,(2012) , 10.3892/MMR.2012.781
David H. Spencer, Haley J. Abel, Christina M. Lockwood, Jacqueline E. Payton, Philippe Szankasi, Todd W. Kelley, Shashikant Kulkarni, John D. Pfeifer, Eric J. Duncavage, Detection of FLT3 internal tandem duplication in targeted, short-read-length, next-generation sequencing data. The Journal of Molecular Diagnostics. ,vol. 15, pp. 81- 93 ,(2013) , 10.1016/J.JMOLDX.2012.08.001
Kenichi Suda, Kenji Tomizawa, Tetsuya Mitsudomi, Biological and clinical significance of KRAS mutations in lung cancer: an oncogenic driver that contrasts with EGFR mutation. Cancer and Metastasis Reviews. ,vol. 29, pp. 49- 60 ,(2010) , 10.1007/S10555-010-9209-4